Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity - PubMed (original) (raw)
Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity
Elizabeth Oldham Hileman et al. Cancer Chemother Pharmacol. 2004 Mar.
Abstract
Purpose: Therapeutic selectivity is one of the most important considerations in cancer chemotherapy. The design of therapeutic strategies to preferentially kill malignant cells while minimizing harmful effects to normal cells depends on our understanding of the biological differences between cancer and normal cells. We have previously demonstrated that certain agents generating reactive oxygen species (ROS) such as 2-methoxyestradiol (2-ME) preferentially kill human leukemia cells without exhibiting significant cytotoxicity in normal lymphocytes. The purpose of the current study was to investigate the biochemical basis for such selective anticancer activity.
Methods: Flow cytometric analyses were utilized to measure intracellular O(2)(-) levels and apoptosis. MTT assays were used as indicators of cellular viability. Western blot analysis was used to measure the expression of antioxidant enzymes in cancer and normal cells.
Results: Malignant cells in general are more active than normal cells in the production of O(2)(-), are under intrinsic oxidative stress, and thus are more vulnerable to damage by ROS-generating agents. The intrinsic oxidative stress in cancer cells was associated with the upregulation of SOD and catalase protein expression, likely as a mechanism to tolerate increased ROS stress. The increase in SOD and catalase expression was observed both in primary human leukemia cells and in primary ovarian cancer cells. Both malignant cell types were more sensitive to 2-ME than their normal counterparts, as demonstrated by the significant accumulation of O(2)(-) and subsequent apoptosis. The administration of ROS scavengers in combination with 2-ME prevented the accumulation of O(2)(-) and abrogated apoptosis induction.
Conclusions: O(2)(-) is an important mediator of 2-ME-induced apoptosis. The increased oxidative stress in cancer cells forces these cells to rely more on antioxidant enzymes such as SOD for O(2)(-) elimination, thus making the malignant cells more vulnerable to SOD inhibition than normal cells.
Similar articles
- Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents.
Zhou Y, Hileman EO, Plunkett W, Keating MJ, Huang P. Zhou Y, et al. Blood. 2003 May 15;101(10):4098-104. doi: 10.1182/blood-2002-08-2512. Epub 2003 Jan 16. Blood. 2003. PMID: 12531810 - Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism.
Pelicano H, Feng L, Zhou Y, Carew JS, Hileman EO, Plunkett W, Keating MJ, Huang P. Pelicano H, et al. J Biol Chem. 2003 Sep 26;278(39):37832-9. doi: 10.1074/jbc.M301546200. Epub 2003 Jul 9. J Biol Chem. 2003. PMID: 12853461 - Superoxide dismutase as a target for the selective killing of cancer cells.
Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Huang P, et al. Nature. 2000 Sep 21;407(6802):390-5. doi: 10.1038/35030140. Nature. 2000. PMID: 11014196 - Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
Fang J, Seki T, Maeda H. Fang J, et al. Adv Drug Deliv Rev. 2009 Apr 28;61(4):290-302. doi: 10.1016/j.addr.2009.02.005. Epub 2009 Feb 26. Adv Drug Deliv Rev. 2009. PMID: 19249331 Review. - Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.
Pani G, Colavitti R, Bedogni B, Fusco S, Ferraro D, Borrello S, Galeotti T. Pani G, et al. Curr Med Chem. 2004 May;11(10):1299-308. doi: 10.2174/0929867043365297. Curr Med Chem. 2004. PMID: 15134521 Review.
Cited by
- Effects of Thyroid Hormones on Cellular Development in Human Ovarian Granulosa Tumor Cells (KGN).
Yu Y, Yao Y, Liu Y, Sun Y, Feng H, Kong N, Chen R, Wu M, Guo S, Tian S, Zhang C. Yu Y, et al. Reprod Sci. 2024 Oct 15. doi: 10.1007/s43032-024-01721-6. Online ahead of print. Reprod Sci. 2024. PMID: 39407059 - Generation of Hydrogen Peroxide in Cancer Cells: Advancing Therapeutic Approaches for Cancer Treatment.
Ali T, Li D, Ponnamperumage TNF, Peterson AK, Pandey J, Fatima K, Brzezinski J, Jakusz JAR, Gao H, Koelsch GE, Murugan DS, Peng X. Ali T, et al. Cancers (Basel). 2024 Jun 7;16(12):2171. doi: 10.3390/cancers16122171. Cancers (Basel). 2024. PMID: 38927877 Free PMC article. Review. - Potential New Therapies "ROS-Based" in CLL: An Innovative Paradigm in the Induction of Tumor Cell Apoptosis.
Sciaccotta R, Gangemi S, Penna G, Giordano L, Pioggia G, Allegra A. Sciaccotta R, et al. Antioxidants (Basel). 2024 Apr 17;13(4):475. doi: 10.3390/antiox13040475. Antioxidants (Basel). 2024. PMID: 38671922 Free PMC article. Review. - Isolation of Fucoxanthin from Sargassum oligocystum Montagne, 1845 Seaweed in Vietnam and Its Neuroprotective Activity.
Hong DD, Thom LT, Ha NC, Thu NTH, Hien HTM, Tam LT, Dat NM, Duc TM, Tru NV, Hang NTM, Ambati RR. Hong DD, et al. Biomedicines. 2023 Aug 19;11(8):2310. doi: 10.3390/biomedicines11082310. Biomedicines. 2023. PMID: 37626806 Free PMC article. - Accurate imaging in the processes of formation and inhibition of drug-induced liver injury by an activable fluorescent probe for ONOO.
Dong J, Yang Y, Fan X, Zhu HL, Li Z. Dong J, et al. Mater Today Bio. 2023 Jun 13;21:100689. doi: 10.1016/j.mtbio.2023.100689. eCollection 2023 Aug. Mater Today Bio. 2023. PMID: 37448665 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources